Log in
ARCA:ELMD

Electromed Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume137,433 shs
Market Capitalization$71.48 million
P/E Ratio17.31
Dividend YieldN/A
Beta0.37
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.42 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone952 758 9299
Employees120

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$32.47 million
Book Value$3.57 per share

Profitability

Net Income$4.16 million

Miscellaneous

Market Cap$71.48 million
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive ELMD News and Ratings via Email

Sign-up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Electromed (ARCA:ELMD) Frequently Asked Questions

What stocks does MarketBeat like better than Electromed?

Wall Street analysts have given Electromed a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Electromed wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Electromed's key competitors?

Who are Electromed's key executives?

Electromed's management team includes the following people:
  • Ms. Kathleen S. Skarvan, CEO, Pres & Director (Age 64, Pay $433.51k)
  • Mr. Michael Joseph MacCourt, CFO, Treasurer & Sec. (Age 42, Pay $266.58k)
  • Mr. Bud Reeves, VP of Sales
  • Mr. William J. George, Sec. (Age 71)
  • Ms. Kathryn Thompson, VP of Reimbursement

What is Electromed's stock symbol?

Electromed trades on the ARCA under the ticker symbol "ELMD."

How do I buy shares of Electromed?

Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

How big of a company is Electromed?

Electromed has a market capitalization of $0.00 and generates $32.47 million in revenue each year. The company earns $4.16 million in net income (profit) each year or $0.47 on an earnings per share basis. Electromed employs 120 workers across the globe.

What is Electromed's official website?

The official website for Electromed is smartvest.com.

How can I contact Electromed?

Electromed's mailing address is 500 SIXTH AVENUE NW, NEW PRAGUE MN, 56071. The company can be reached via phone at 952 758 9299.

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.